SynthesisCNS drugs2026

Approved Medications for Substance Use Disorders: An Umbrella Review of Systematic Reviews and Completed Phase 3 Randomized Controlled Trials.

Itai Danovitch et al.PubMed ↗Publisher ↗

No numbers read from the abstract.